Products

Mogamulizumab (Gly-007CL)

Mogamulizumab (USAN; trade name Poteligeo) is a humanized monoclonal antibody targeting CC chemokine receptor 4 (CCR4). It was approved in 2012 for the treatment of relapsed or refractory adult T-cell leukemia/lymphoma.      

  • Datasheet

Specifications
Type
Humanized (from mouse) Whole antibody
Protein Chemical Formula
C6520H10072N1736O2020S42
Protein Average Weight
146.44 kg/mol
CAS NO.
1159266-37-1
Mechanism of Action
CCR4 receptor antagonists
References
Alternative Names
Poteligeo (mogamulizumab; AMG-761; KW-0761); AMG 761; KM8761

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Increase Efficiency to Accelerate Your Research & Discovery Process

Increase Efficiency to Accelerate Your Research & 
Discovery Process

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production ...

Find out more >

USA

45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356

Europe

Tel: 44-207-097-1828
Email:
Follow us on:
           

Terms of Service-Privacy Policy     © 2007 - 2019 Creative-Biolabs All Rights Reserved